Jayaraman et al. [52] have reported that iNOS inhibition enhances the accumulation of Tregs in tumor-bearing mice, and a combination therapy strategy for myeloid-derived suppressor cells (MDSCs) and Tregs can be applied, which may lead to significant recovery of the body’s immune function. This evidence concerns the gene NOS2 and neoplasm.